The depletion of KDM6B reduced the stemness of hepatocellular cancer cells, and JIB-04, a KDM4/6 inhibitor, significantly reduced the level of expression of stem cell marker genes (CD133/PROM1, CD44, LGR5, EpCAM) [73]. This evidence concerns the gene PROM1 and hepatocellular carcinoma.